What question did this study set out to answer?

To assess genotype-specific sensitivity biases of commonly used HPV consensus primer sets in cervical cancer tissue specimens.

July 19, 2005International Journal of CancerOpen Access

Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers

View Full Paper

Ask AI

Bookmark

To assess genotype-specific sensitivity biases of commonly used HPV consensus primer sets in cervical cancer tissue specimens.
Tested 3 consensus primer sets (GP5+/6+, MY09/11, and PGMY09/11) in parallel.
Analyzed N=120 cervical cancer specimens (squamous cell cervical carcinoma) from Chinese patients in Hong Kong.
GP5+/6+ demonstrated poor sensitivity for HPV52, underestimating its prevalence in squamous cell cervical cancer from 14.6% to 0%.
Failure of GP5+/6+ to detect HPV52 completely concealed its true standing as the second most prevalent genotype in this population.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Comparative study reveals consensus primer sensitivity bias underestimating HPV52 prevalence in cervical cancer specimens, highlighting risks of misprioritizing vaccine targets.

Cite This Study

Chan et al. (2005) studied this question.

synapsesocial.com/papers/6a94124efb64bc8805215572 https://doi.org/10.1002/ijc.21299

View Full Paper

Ask AI

Bookmark

Implication

Comparative study reveals consensus primer sensitivity bias underestimating HPV52 prevalence in cervical cancer specimens, highlighting risks of misprioritizing vaccine targets.

Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers

Key Points

Discussion

Implication

Cite This Study

Biases in human papillomavirus genotype prevalence assessment associatedwith commonly used consensus primers

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider